gpt-4o-mini
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.
{
  "first_pass": {
    "id": "chatcmpl-c9be4c3a-78c2-4b6b-8aa3-31e1af7cea0f",
    "choices": [
      {
        "finish_reason": "stop",
        "index": 0,
        "logprobs": null,
        "message": {
          "content": "In the Philippines, the use of a \"red dot\" symbol on prescription-only pharmaceutical products is not mandated. Instead, the labeling requirements for such products are specified in Republic Act No. 5921, also known as the Pharmacy Law. This act outlines the necessary information to be included on labels for dispensed medicines.\n\nAccording to Section 31 of Republic Act No. 5921, every box, bottle, or package containing medicine sold or dispensed by a pharmacist based on a prescription must have a label bearing, among other details, the name of the prescriber, date, and number of the prescription, as well as directions for use. For prescriptions that contain any quantity of a habit-forming drug or its derivative, the label must include the statement \"Warning\u2014may be habit forming.\" Additionally, prescriptions for external use filled in the drugstore must bear a red label showing in black ink the components of the prescription and the words \"For external use only\" at the bottom of the label. ([elibrary.judiciary.gov.ph](https://elibrary.judiciary.gov.ph/thebookshelf/showdocs/2/18576?utm_source=openai))\n\nFurthermore, the Food and Drug Administration (FDA) of the Philippines has issued guidelines specifying that the labeling materials of prescription drug products must always include the Rx symbol, which should be prominently displayed. The caution statement, \"Foods, Drugs, Devices, and Cosmetics Act prohibits dispensing without prescription,\" must also be included in the package insert, unit carton, primary label (except blister pack, foil strip, and small containers) of prescription drug products. ([fr.scribd.com](https://fr.scribd.com/document/430375236/Drug-Approval-System-of-the-Philippines-pdf?utm_source=openai))\n\nTherefore, while a red label is required for external-use prescriptions, there is no specific mandate for a \"red dot\" symbol on prescription-only pharmaceutical products in the Philippines. ",
          "refusal": null,
          "role": "assistant",
          "annotations": [
            {
              "type": "url_citation",
              "url_citation": {
                "end_index": 1116,
                "start_index": 1004,
                "title": "REPUBLIC ACT NO. 5921 - AN ACT REGULATING THE PRACTICE OF PHARMACY AND SETTING STANDARDS OF PHARMACEUTICAL EDUCATION IN THE PHILIPPINES AND FOR OTHER PURPOSES. - Supreme Court E-Library",
                "url": "https://elibrary.judiciary.gov.ph/thebookshelf/showdocs/2/18576?utm_source=openai"
              }
            },
            {
              "type": "url_citation",
              "url_citation": {
                "end_index": 1743,
                "start_index": 1622,
                "title": "Drug Approval System of The Philippines PDF | PDF | Clinical Trial | Food And Drug Administration",
                "url": "https://fr.scribd.com/document/430375236/Drug-Approval-System-of-the-Philippines-pdf?utm_source=openai"
              }
            }
          ],
          "audio": null,
          "function_call": null,
          "tool_calls": null
        }
      }
    ],
    "created": 1756270105,
    "model": "gpt-4o-mini-search-preview-2025-03-11",
    "object": "chat.completion",
    "service_tier": null,
    "system_fingerprint": "",
    "usage": {
      "completion_tokens": 395,
      "prompt_tokens": 67,
      "total_tokens": 462,
      "completion_tokens_details": {
        "accepted_prediction_tokens": 0,
        "audio_tokens": 0,
        "reasoning_tokens": 0,
        "rejected_prediction_tokens": 0
      },
      "prompt_tokens_details": {
        "audio_tokens": 0,
        "cached_tokens": 0
      }
    }
  },
  "second_pass": {
    "id": "resp_68ae8e1ea57c819db101ce07a233e2c608b00319a160fa69",
    "created_at": 1756270110.0,
    "error": null,
    "incomplete_details": null,
    "instructions": null,
    "metadata": {},
    "model": "gpt-4o-mini-2024-07-18",
    "object": "response",
    "output": [
      {
        "id": "msg_68ae8e1f0d84819db859f97ad5c1354e08b00319a160fa69",
        "content": [
          {
            "annotations": [],
            "text": "{\"status\":\"NO\",\"explanation\":\"The Philippines does not specifically mandate the use of a 'red dot' symbol on prescription-only pharmaceutical products as indicated by Republic Act No. 5921 and FDA guidelines, which focus instead on other labeling requirements.\",\"sources\":[\"https://elibrary.judiciary.gov.ph/thebookshelf/showdocs/2/18576?utm_source=openai\",\"https://fr.scribd.com/document/430375236/Drug-Approval-System-of-the-Philippines-pdf?utm_source=openai\"]}",
            "type": "output_text",
            "logprobs": [],
            "parsed": {
              "status": "NO",
              "explanation": "The Philippines does not specifically mandate the use of a 'red dot' symbol on prescription-only pharmaceutical products as indicated by Republic Act No. 5921 and FDA guidelines, which focus instead on other labeling requirements.",
              "sources": [
                "https://elibrary.judiciary.gov.ph/thebookshelf/showdocs/2/18576?utm_source=openai",
                "https://fr.scribd.com/document/430375236/Drug-Approval-System-of-the-Philippines-pdf?utm_source=openai"
              ]
            }
          }
        ],
        "role": "assistant",
        "status": "completed",
        "type": "message"
      }
    ],
    "parallel_tool_calls": true,
    "temperature": 1.0,
    "tool_choice": "auto",
    "tools": [],
    "top_p": 1.0,
    "background": false,
    "conversation": null,
    "max_output_tokens": null,
    "max_tool_calls": null,
    "previous_response_id": null,
    "prompt": null,
    "prompt_cache_key": null,
    "reasoning": {
      "effort": null,
      "generate_summary": null,
      "summary": null
    },
    "safety_identifier": null,
    "service_tier": "default",
    "status": "completed",
    "text": {
      "format": {
        "name": "QueryResponse",
        "schema_": {
          "$defs": {
            "Status": {
              "enum": [
                "YES",
                "NO",
                "PARTIAL",
                "UNKNOWN"
              ],
              "title": "Status",
              "type": "string"
            }
          },
          "properties": {
            "status": {
              "description": "Status of the policy for the given country",
              "enum": [
                "YES",
                "NO",
                "PARTIAL",
                "UNKNOWN"
              ],
              "title": "Status",
              "type": "string"
            },
            "explanation": {
              "description": "1 sentence explanation of the status with citations",
              "title": "Explanation",
              "type": "string"
            },
            "sources": {
              "description": "A list of URLs cited in the explanation",
              "items": {
                "type": "string"
              },
              "title": "Sources",
              "type": "array"
            }
          },
          "required": [
            "status",
            "explanation",
            "sources"
          ],
          "title": "QueryResponse",
          "type": "object",
          "additionalProperties": false
        },
        "type": "json_schema",
        "description": null,
        "strict": true
      },
      "verbosity": "medium"
    },
    "top_logprobs": 0,
    "truncation": "disabled",
    "usage": {
      "input_tokens": 1546,
      "input_tokens_details": {
        "cached_tokens": 0
      },
      "output_tokens": 109,
      "output_tokens_details": {
        "reasoning_tokens": 0
      },
      "total_tokens": 1655
    },
    "user": null,
    "store": true
  }
}